WESTLAKE VILLAGE, Calif.–(BUSINESS WIRE)–Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief Executive Officer, will deliver a company presentation as part of the Jefferies Global Healthcare Conference in London. Presentation details are as follows: Date: Monday, November 16, 2026 Time: 10:30 AM – 10:55 AM ET (3:30 PM – 3:55 PM GMT) The Company will